UK markets open in 3 hours 13 minutes


Copenhagen - Copenhagen Real-time price. Currency in DKK
Add to watchlist
840.50-3.50 (-0.41%)
At close: 04:59PM CET
Full screen
Previous close844.00
Bid836.50 x 0
Ask838.50 x 0
Day's range820.00 - 848.50
52-week range540.00 - 952.50
Avg. volume36,175
Market cap14.627B
Beta (5Y monthly)1.59
PE ratio (TTM)92.16
EPS (TTM)9.12
Earnings date09 Feb 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend date09 Oct 2020
1y target est1,000.00
  • Globe Newswire

    Q1 2022/23 - Good start to the fiscal year with 34% revenue growth

    ANNOUNCEMENT NO. 232 Trading statement for Q1 2022/23 (1 July - 30 September 2022) Good start to the fiscal year with 34% revenue growth The financial year 2022/23 is off to a good start with revenue up 34% in the first quarter to DKK 113.8 million from DKK 85.0 million in the year-earlier period. While all product segments recorded growth, the North American market remains the main geographical growth driver. EBITDA amounted to DKK 65.2 million, a year-on-year increase of 50%, for an EBITDA mar

  • Globe Newswire

    Annual Report 2021/22 - Strong growth despite challenging conditions

    ANNOUNCEMENT NO. 229 15 September 2022 Annual Report 2021/22 (1 July 2021 - 30 June 2022) Strong growth despite challenging conditions ChemoMetec grew its revenue by 52% in 2021/22 from DKK 281.1 million to DKK 427.2 million despite the extraordinary market conditions caused by Covid-19 and the war in Ukraine, including supply chain shortages. As a result, EBITDA grew from DKK 135.6 million to DKK 222.9 million, a 64% increase. As in previous years, growth was primarily driven by increasing sale

  • Globe Newswire

    ChemoMetec-aktien rykker til Large Cap

    PRESSEMEDDELELSE 29. december 2021 ChemoMetec-aktien rykker til Large Cap Fra og med den 3. januar 2022 rykker ChemoMetec-aktien fra Mid Cap til Large Cap-segmentet på Nasdaq Copenhagen. Large Cap-segmentet består af virksomheder, hvis markedsværdi overstiger 1 mia. euro. ChemoMetecs markedsværdi udgør i dag ca. 14 mia. kr. ChemoMetec ser frem til at være en del af Large Cap-segmentet, og ser det som en kvittering for, at såvel vores strategi og daglige arbejde skaber værdi for vores aktionærer.